IN THE COURT OF APPEALS OF THE STATE OF WASHINGTON
MEGHAN A. McSORLEY, No. 86325-8-I Respondent, DIVISION ONE v. PUBLISHED OPINION THE EVERETT CLINIC, a Washington professional limited liability company; NARIMAN HESHMATI, an individual; and ALBERT FISK, an individual,
Petitioners,
OPTUM CARE SERVICES COMPANY, a Minnesota corporation, f/d/b/a DaVITA MEDICAL GROUP; OPTUM CARE, INC., a Minnesota corporation, f/d/b/a DaVITA MEDICAL GROUP,
Defendants.
BIRK, J. — The Everett Clinic (TEC) seeks discretionary review of a
discovery order compelling it to disclose privileged material subject to the peer
review and quality improvement privileges. Dr. Meghan McSorley brought a
Washington Law Against Discrimination (WLAD), ch. 49.60 RCW, disparate
treatment claim against TEC, her former employer. During discovery, TEC was
granted a protective order as to its privileged peer review and quality improvement
files, which it later partially waived, disclosing only Dr. McSorley’s file. Dr.
McSorley sought an order compelling disclosure of other privileged peer review No. 86325-8-I/2
and quality improvement files, specifically for alleged WLAD comparator Dr.
Nariman Heshmati. Because Dr. Heshmati’s peer review and quality improvement
file was part of the same subject matter as Dr. McSorley’s, fairness required the
disclosure of Dr. Heshmati’s file. We affirm.
I
In June 2021, Dr. McSorley filed a complaint against, among others, TEC
and its partner and obstetrics and gynecology (OB/GYN) specialist, Dr. Heshmati,
alleging violations of WLAD and wrongful termination in violation of public policy.
Dr. McSorley, an employee of TEC from 2016 to 2019, claimed Dr. Heshmati was
regularly disrespectful to her, undermined her, and investigated and criticized her
behind her back—behavior he did not direct towards male doctors. Dr. McSorley
raised concerns about Dr. Heshmati’s practice and “systemic quality control
deficiencies that had led to bad patient outcomes.” Dr. McSorley alleged these
concerns were not properly investigated by TEC.
Dr. McSorley claimed Dr. Heshmati used the peer review and quality
assurance systems at TEC to lodge meritless complaints against her. Dr.
McSorley alleges she submitted a letter to the head of the Quality Review
Committee for TEC, where she raised concerns over Dr. Heshmati’s management
of patient care. In response, Dr. McSorley claims she had an off the record
meeting with Dr. Albert Fisk, the Chief Medical Officer at TEC, in which she was
asked to voluntarily relinquish her hospital privileges by end of day. After
protesting the request by e-mail, which she refers to as “a formal complaint of
gender discrimination and retaliation, including whistleblower retaliation,” Dr.
2 No. 86325-8-I/3
McSorley alleges that “[l]ess than one hour later, Dr. Fisk removed [her] ability to
practice medicine at the Clinic entirely.”
Dr. McSorley asserts that after she passed a “demeaning” and “remedial”
assessment that TEC required, TEC delayed reinstating her, and when Dr. Fisk
finally did begin the reinstatement process, he refused to apologize, compensate
her for lost performance bonuses, or assist her in reestablishing her practice. Due
to her continuing fear of gender-based discrimination, Dr. McSorley chose not to
practice medicine at TEC again.
During discovery, Dr. McSorley sought documents related to TEC’s
response to complaints raised against her and other similarly situated male
OB/GYN comparators. In February 2022, Dr. McSorley moved to compel TEC to
produce all documents identified in its privilege logs, not generated, created, and
maintained exclusively by the peer review committee. In July 2022, after
conducting an in camera review, the superior court ordered the petitioners to
produce numerous documents identified in the privilege log, while not ordering
disclosure of others. The order conformed the privilege narrowly to those
documents created exclusively for review committees.1
Then in 2023, TEC waived peer review and quality improvement privileges
for “any and all files, facts, and testimony regarding” Dr. McSorley’s peer review,
and produced those documents. TEC provided little explanation for its reversal in
strategy, stating, “In order to provide context to the documents that [the superior
1 See Lowy v. Peacehealth, 174 Wn.2d 769, 778, 280 P.3d 1078 (2012) (strictly construing peer review and quality improvement privileges).
3 No. 86325-8-I/4
court] ordered to be produced, on June 16, 2023, TEC produced the rest of the
documents related to [Dr. McSorley’s] peer review file.”2 Dr. McSorley moved to
compel production of Dr. Heshmati’s peer review file, asserting that TEC had
waived privilege by partially and selectively disclosing Dr. McSorley’s peer review
file and that in fairness, TEC should be ordered to produce at least Dr. Heshmati’s
peer review file as well, arguing he was a proper comparator for purposes of her
discrimination claim. Dr. McSorley also suggested she would seek similar
documents for other comparators.
The superior court granted Dr. McSorley’s motion to compel. The superior
court ruled that the test for implied waiver had been satisfied, that, for purposes of
discovery, Dr. Heshmati was a proper comparator, and that in fairness his peer
review file had to be produced. The superior court certified its order for
discretionary review under RAP 2.3(b)(4). A commissioner of this court granted
discretionary review under that rule. TEC maintains that its waiver of the peer
review and quality improvement privileges is limited to Dr. McSorley’s peer review
file it disclosed, and that the superior court erred by compelling further disclosure.
II
The superior court ruled that TEC made an intentional3 and selective
disclosure of privileged information and it was appropriate to compel production of
2 One document disclosed was a case review summary in which a reviewer
assessing Dr. McSorley denoted a concern with the standard of care, issues with quality, and the opinion that Dr. McSorley’s ministrations “[p]robably did contribute to harm” in the reviewed case. Other documents disclosed included e-mails in which Dr. McSorley’s care for two patients was critiqued. 3 We are concerned in this case with intentional disclosure of privileged
information. We analyzed inadvertent disclosure in Sitterson v. Evergreen Sch.
4 No. 86325-8-I/5
other privileged documents necessary to fairly adjudicate Dr. McSorley’s disparate
treatment claims. We agree. The general rule, codified in ER 502(a) for the
attorney-client privilege and the work product doctrine, is that when a party makes
a partial disclosure of privileged documents, it waives privilege also for documents
relating to the same subject matter and that ought in fairness to be considered
together. Whether a waiver of privilege was made is reviewed de novo.4 Magney
v. Truc Pham, 195 Wn.2d 795, 801, 466 P.3d 1077 (2020).
A
The Washington Supreme Court considered the effect of a partial disclosure
of privileged material in McUne v. Fuqua, where a litigant claiming personal injury
from an automobile collision presented at trial his own testimony and that of three
Free access — add to your briefcase to read the full text and ask questions with AI
IN THE COURT OF APPEALS OF THE STATE OF WASHINGTON
MEGHAN A. McSORLEY, No. 86325-8-I Respondent, DIVISION ONE v. PUBLISHED OPINION THE EVERETT CLINIC, a Washington professional limited liability company; NARIMAN HESHMATI, an individual; and ALBERT FISK, an individual,
Petitioners,
OPTUM CARE SERVICES COMPANY, a Minnesota corporation, f/d/b/a DaVITA MEDICAL GROUP; OPTUM CARE, INC., a Minnesota corporation, f/d/b/a DaVITA MEDICAL GROUP,
Defendants.
BIRK, J. — The Everett Clinic (TEC) seeks discretionary review of a
discovery order compelling it to disclose privileged material subject to the peer
review and quality improvement privileges. Dr. Meghan McSorley brought a
Washington Law Against Discrimination (WLAD), ch. 49.60 RCW, disparate
treatment claim against TEC, her former employer. During discovery, TEC was
granted a protective order as to its privileged peer review and quality improvement
files, which it later partially waived, disclosing only Dr. McSorley’s file. Dr.
McSorley sought an order compelling disclosure of other privileged peer review No. 86325-8-I/2
and quality improvement files, specifically for alleged WLAD comparator Dr.
Nariman Heshmati. Because Dr. Heshmati’s peer review and quality improvement
file was part of the same subject matter as Dr. McSorley’s, fairness required the
disclosure of Dr. Heshmati’s file. We affirm.
I
In June 2021, Dr. McSorley filed a complaint against, among others, TEC
and its partner and obstetrics and gynecology (OB/GYN) specialist, Dr. Heshmati,
alleging violations of WLAD and wrongful termination in violation of public policy.
Dr. McSorley, an employee of TEC from 2016 to 2019, claimed Dr. Heshmati was
regularly disrespectful to her, undermined her, and investigated and criticized her
behind her back—behavior he did not direct towards male doctors. Dr. McSorley
raised concerns about Dr. Heshmati’s practice and “systemic quality control
deficiencies that had led to bad patient outcomes.” Dr. McSorley alleged these
concerns were not properly investigated by TEC.
Dr. McSorley claimed Dr. Heshmati used the peer review and quality
assurance systems at TEC to lodge meritless complaints against her. Dr.
McSorley alleges she submitted a letter to the head of the Quality Review
Committee for TEC, where she raised concerns over Dr. Heshmati’s management
of patient care. In response, Dr. McSorley claims she had an off the record
meeting with Dr. Albert Fisk, the Chief Medical Officer at TEC, in which she was
asked to voluntarily relinquish her hospital privileges by end of day. After
protesting the request by e-mail, which she refers to as “a formal complaint of
gender discrimination and retaliation, including whistleblower retaliation,” Dr.
2 No. 86325-8-I/3
McSorley alleges that “[l]ess than one hour later, Dr. Fisk removed [her] ability to
practice medicine at the Clinic entirely.”
Dr. McSorley asserts that after she passed a “demeaning” and “remedial”
assessment that TEC required, TEC delayed reinstating her, and when Dr. Fisk
finally did begin the reinstatement process, he refused to apologize, compensate
her for lost performance bonuses, or assist her in reestablishing her practice. Due
to her continuing fear of gender-based discrimination, Dr. McSorley chose not to
practice medicine at TEC again.
During discovery, Dr. McSorley sought documents related to TEC’s
response to complaints raised against her and other similarly situated male
OB/GYN comparators. In February 2022, Dr. McSorley moved to compel TEC to
produce all documents identified in its privilege logs, not generated, created, and
maintained exclusively by the peer review committee. In July 2022, after
conducting an in camera review, the superior court ordered the petitioners to
produce numerous documents identified in the privilege log, while not ordering
disclosure of others. The order conformed the privilege narrowly to those
documents created exclusively for review committees.1
Then in 2023, TEC waived peer review and quality improvement privileges
for “any and all files, facts, and testimony regarding” Dr. McSorley’s peer review,
and produced those documents. TEC provided little explanation for its reversal in
strategy, stating, “In order to provide context to the documents that [the superior
1 See Lowy v. Peacehealth, 174 Wn.2d 769, 778, 280 P.3d 1078 (2012) (strictly construing peer review and quality improvement privileges).
3 No. 86325-8-I/4
court] ordered to be produced, on June 16, 2023, TEC produced the rest of the
documents related to [Dr. McSorley’s] peer review file.”2 Dr. McSorley moved to
compel production of Dr. Heshmati’s peer review file, asserting that TEC had
waived privilege by partially and selectively disclosing Dr. McSorley’s peer review
file and that in fairness, TEC should be ordered to produce at least Dr. Heshmati’s
peer review file as well, arguing he was a proper comparator for purposes of her
discrimination claim. Dr. McSorley also suggested she would seek similar
documents for other comparators.
The superior court granted Dr. McSorley’s motion to compel. The superior
court ruled that the test for implied waiver had been satisfied, that, for purposes of
discovery, Dr. Heshmati was a proper comparator, and that in fairness his peer
review file had to be produced. The superior court certified its order for
discretionary review under RAP 2.3(b)(4). A commissioner of this court granted
discretionary review under that rule. TEC maintains that its waiver of the peer
review and quality improvement privileges is limited to Dr. McSorley’s peer review
file it disclosed, and that the superior court erred by compelling further disclosure.
II
The superior court ruled that TEC made an intentional3 and selective
disclosure of privileged information and it was appropriate to compel production of
2 One document disclosed was a case review summary in which a reviewer
assessing Dr. McSorley denoted a concern with the standard of care, issues with quality, and the opinion that Dr. McSorley’s ministrations “[p]robably did contribute to harm” in the reviewed case. Other documents disclosed included e-mails in which Dr. McSorley’s care for two patients was critiqued. 3 We are concerned in this case with intentional disclosure of privileged
information. We analyzed inadvertent disclosure in Sitterson v. Evergreen Sch.
4 No. 86325-8-I/5
other privileged documents necessary to fairly adjudicate Dr. McSorley’s disparate
treatment claims. We agree. The general rule, codified in ER 502(a) for the
attorney-client privilege and the work product doctrine, is that when a party makes
a partial disclosure of privileged documents, it waives privilege also for documents
relating to the same subject matter and that ought in fairness to be considered
together. Whether a waiver of privilege was made is reviewed de novo.4 Magney
v. Truc Pham, 195 Wn.2d 795, 801, 466 P.3d 1077 (2020).
A
The Washington Supreme Court considered the effect of a partial disclosure
of privileged material in McUne v. Fuqua, where a litigant claiming personal injury
from an automobile collision presented at trial his own testimony and that of three
doctors about his physical ailments and disabilities. 42 Wn.2d 65, 68, 74-76, 253
P.2d 632 (1953). The opposing party sought to introduce the testimony of other
doctors who would testify that the plaintiff had similar complaints predating the
collision. Id. at 73. The court held the plaintiff’s testimony at trial was a waiver,
but limited to testimony regarding “the same ailments and disabilities.” Id. at 76.
McUne asks whether there is “such relation between the old and new medical
Dist. No. 114, 147 Wn. App. 576, 584-88, 196 P.3d 735 (2008), and adopted a five-part test to assess waiver on an inadvertent basis. 4 Case law leaves open the possibility that a trial court’s determination of
the extent to which fairness requires further disclosure is a discretionary decision, reviewed for abuse of discretion. Magney, 195 Wn.2d at 799 (“[W]e conclude that the discretion of whether a privilege has been impliedly waived belongs to the trial court judge, who has access to the entirety of the record of the case and who can determine whether any disclosures thus far impliedly waived the privilege.”). Because we affirm based on a de novo review, we do not consider whether the abuse of discretion standard governs review of the extent of a given waiver.
5 No. 86325-8-I/6
testimony that appellant’s production of the former constituted a waiver of the
privilege as to the latter.”5 Id. at 77 (emphasis added).
McUne applied the rule of subject matter waiver. Under this rule,
When a party reveals part of a privileged communication in order to gain an advantage in litigation, it waives the privilege as to all other communications relating to the same subject matter because “the privilege of secret consultation is intended only as an incidental means of defense and not as an independent means of attack, and to use it in the latter character is to abandon it in the former.”
In re Sealed Case, 676 F.2d 793, 818 (D.C. Cir. 1982) (quoting 8 J. WIGMORE,
EVIDENCE IN TRIALS AT C OMMON LAW § 2327, at 638 (J. McNaughton rev. 1961)).
Selective disclosure of privileged material risks conveying an incomplete or even
misleading picture to the trier of fact, because the privilege holder might unfairly
disclose parts of privileged material that seem to support its position, while
withholding context or other material undercutting its position. 2 EDWARD J.
IMWINKELREID, THE NEW WIGMORE: A TREATISE ON EVIDENCE § 6.12.7, at 1114-15
(2d ed. 2010).
5 Like McUne, our case involves waiver through partial disclosure. A different type of waiver occurs when a party asserts a contention in litigation that puts privileged information at issue. See Pappas v. Holloway, 114 Wn.2d 198, 203, 207, 787 P.2d 30 (1990) (counterclaiming for legal malpractice); Steel v. Phila. Indem. Ins. Co., 195 Wn. App. 811, 816, 832, 381 P.3d 111 (2016) (seeking a reasonableness determination of a covenant judgment settlement); cf. Chevron Corp v. Pennzoil Co., 974 F.2d 1156, 1162 (9th Cir. 1992) (raising an affirmative defense) (“Where a party raises a claim which in fairness requires disclosure of the protected communication, the privilege may be implicitly waived.”). In those situations, Washington applies its version of “the Hearn test,” Steel, 195 Wn. App. at 832, a framework derived from Hearn v. Rhay, 68 F.R.D. 574 (E.D. Wash. 1975). At the parties’ urging, the superior court used the Hearn framework to analyze and determine the extent to which fairness required further disclosure by TEC. Although the two kinds of waiver are analytically distinct, the superior court’s thorough order covered the points relevant to the analysis of TEC’s waiver through partial disclosure.
6 No. 86325-8-I/7
The modern trend has been to limit subject matter waiver to additional
material on the same subject that fairness requires to be disclosed “to avoid
prejudice to the adversary party and ‘distortion of the judicial process’ that may
result from selective disclosure.” In re Actos Antitrust Litig., 628 F. Supp. 3d 524,
533 (S.D.N.Y. 2022) (quoting In re von Bulow, 828 F.2d 94, 101 (2d Cir. 1987)). A
version of subject matter waiver has been adopted by rule for the attorney-client
privilege and the work product doctrine in Washington proceedings under ER 502,
patterned after Federal Rules of Evidence 502. Under this rule, subject matter
waiver going beyond the information actually disclosed is “reserved for those
unusual situations in which fairness requires a further disclosure of related,
protected information, in order to prevent a selective and misleading presentation
of evidence to the disadvantage of the adversary.” FED. R. EVID. 502 advisory
committee note.
Finally, in determining whether a party has waived privilege, courts may
consider the purpose the privilege is meant to serve. Carson v. Fine, 123 Wn.2d
206, 214, 867 P.2d 610 (1994) (analyzing the scope of waiver: “Waiver occurs
because the purpose of the privilege no longer exists.”); Pappas v. Holloway, 114
Wn.2d 198, 208, 787 P.2d 30 (1990) (characterizing waiver analysis in part as
limiting the attorney-client privilege to “the purpose for which it exists.”); cf. Steel
v. Phila. Indem. Ins. Co., 195 Wn. App. 811, 825, 381 P.3d 111 (2016) (requiring
case-by-case justification for application of implied waiver test). When a party’s
use of a privilege fits with the intended purpose of a privilege, a finding of waiver
is less likely. In contrast, when a party’s use of a privilege is not consistent with
7 No. 86325-8-I/8
the purpose the privilege serves, then both a finding of waiver and a finding of a
greater extent of waiver are more likely. In such a case, the party’s actions indicate
that it is not concerned with protecting the interests that were meant to be protected
by the privilege. Cf. Sealed Case, 676 F.2d at 818 (courts need not allow a claim
of privilege “when the party claiming the privilege seeks to use it in a way that is
not consistent with the purpose of the privilege.”).
B
TEC acknowledges that subject matter waiver is the appropriate analysis,
but argues that the “subject matter” of its disclosure is limited to Dr. McSorley’s
peer review file, which it has already disclosed. It argues that the peer review files
of any other physician would be a different subject matter. We disagree.
The superior court appropriately defined the subject matter of TEC’s
disclosure not in an arbitrary, abstract sense, but in the context of the issues being
litigated. Decisions analyzing subject matter waiver are illustrative. In Actos,
where the privilege holder had described two patents as ones that “ ‘claim’ ” a
brand name drug for purpose of competition from generic drugs, it asserted a
defense requiring it to show that it, in good faith, relied on advice that the
descriptions were required by regulation. 628 F. Supp. 3d at 531, 534. The
privilege holder waived privilege as to documents relating to the applicability of and
its compliance with certain regulations. Id. at 536. The court found the proposed
scope of the waiver might result in the privilege holder selectively withholding
documents rebutting its good faith conclusion that its descriptions were required
by the regulations. Id. Thus a subject matter broader than the disclosure itself
8 No. 86325-8-I/9
was implicated. Id. And where a party maintained its tax position was reasonable
“because it was based on advice of counsel,” the party put at issue “the tax advice
it received.” Chevron Corp v. Pennzoil Co., 974 F.2d 1156, 1162-63 (9th Cir.
1992). Withholding material informing “the extent” of the party’s knowledge would
“deny [the plaintiff] access to the very information that [it] must refute in order to
demonstrate” the defendant’s misconduct. Id. In contrast, in Weil v.
Investment/Indicators, Research & Management, Inc., a privilege waiver made
early in litigation, that was limited in scope and not prejudicial to the opposing party,
did not compel further disclosure. 647 F.2d 18, 25 (9th Cir. 1981).
TEC’s position is that it can use Dr. McSorley’s peer review file to support
its “good faith, reasonable basis” for conducting a peer review of Dr. McSorley. If
a plaintiff makes a prima facie showing of discrimination, then the burden shifts to
the defendant to “ ‘articulate a legitimate, nondiscriminatory reason for the adverse
employment action,’ ” and if the defendant meets that burden the plaintiff must
produce evidence showing the plaintiff’s reasons were pretextual. Mikkelsen v.
Pub. Util. Dist. No. 1 of Kittitas County, 189 Wn.2d 516, 527, 404 P.3d 464 (2017)
(quoting Scrivener v. Clark Coll., 181 Wn.2d 439, 446, 334 P.3d 541 (2014)).
TEC’s interest in using Dr. McSorley’s peer review file is in articulating a
“legitimate, nondiscriminatory reason” for its actions towards her. Id. If TEC was
given similar reasons to take action against male comparators but took none, it
would support the inference that a substantial factor in its actions towards Dr.
McSorley was her gender. Scrivener, 181 Wn.2d at 446-47 (“An employee may
satisfy the pretext prong by offering sufficient evidence . . . (1) that the defendant’s
9 No. 86325-8-I/10
reason is pretextual or (2) that although the employer’s stated reason is legitimate,
discrimination nevertheless was a substantial factor motivating the employer.”).
The superior court appropriately found that the relevance of the material to the
action defined the subject matter for purposes of waiver: the disclosed documents
allowed petitioners to “attack the quality” of Dr. McSorley’s medical care “and
proffer an alternative explanation for the adverse actions against her as a defense.”
(Emphasis added.) In the context of the litigation, the subject matter of TEC’s
disclosure of privileged material is appropriately defined as the justification for the
actions taken against Dr. McSorley.
The superior court also appropriately determined that compelling a similar
disclosure for male comparators was the fair requirement—and the fair limit—for
additional disclosure. In some instances, the fairness standard might mean little
or nothing additional needs to be disclosed after a waiver. See e.g., Weil, 647
F.2d at 25. Here, under longstanding principles governing employment
discrimination cases, courts assess an employer’s justification not just from what
the employer claims, but from circumstantial evidence of its treatment of
comparators. Mikkelsen, 189 Wn.2d at 526 (direct evidence of discrimination is
rare, which is why “plaintiffs may rely on circumstantial, indirect, and inferential
evidence to establish discriminatory action.”). As the superior court explained,
TEC’s disclosure gave it an advantage “by allowing negative comments about Dr.
McSorley to be discovered and discussed, without allowing analogous negative
comments about Dr. Heshmati to be discovered and discussed.” In a disparate
10 No. 86325-8-I/11
treatment claim, disclosure of the former without disclosure of the latter would
amount to a selective and potentially misleading portrayal of the facts.
Thus far, the superior court has ruled only that Dr. Heshmati is a proper
comparator for whom documents equivalent to those disclosed about Dr. McSorley
must be produced. Contrary to TEC’s fear, this does not give Dr. McSorley the
unilateral ability to define the scope of discovery. The superior court’s ruling
logically limits further disclosure to equivalent peer review documents as to other
doctors whom the court views as proper comparators. TEC does not precisely
challenge the superior court’s view that Dr. Heshmati is a proper comparator for
purposes of discovery. And the record provides ample justification for the superior
court’s well-reasoned ruling in light of its broad discretion to determine the scope
of discovery. Nakata v. Blue Bird, Inc., 146 Wn. App. 267, 277, 191 P.3d 900
(2008) (“A trial court has broad discretion under CR 26 to manage the discovery
process.”). With Dr. McSorley having so far identified one, or perhaps two,
comparators after years of discovery, we see little risk that the superior court’s
ruling threatens an unfairly expansive definition of comparators for purposes of
waiver. The superior court imposed a fair, reasonable, and clear limit on the extent
of the privilege waiver.
Finally, both the conclusion of waiver here and its extent are appropriate in
light of the purposes of the peer review and quality improvement privileges. See
Carson, 123 Wn.2d at 214. “The general purpose of the peer review statute is to
encourage health care providers to candidly review the work and behavior of their
colleagues to improve health care.” Lowy v. Peacehealth, 174 Wn.2d 769, 774,
11 No. 86325-8-I/12
280 P.3d 1078 (2012). TEC’s disclosure to serve its strategic interests in an
employment discrimination lawsuit with a former employee only undermines these
purposes. For the purpose of a privilege to be served, “the participants in the
confidential conversation ‘must be able to predict with some degree of certainty
whether particular discussions will be protected. An uncertain privilege, or one
which purports to be certain but results in widely varying applications by the courts,
is little better than no privilege at all.’ ” Jaffee v. Redmond, 518 U.S 1, 18, 116 S.
Ct. 1923, 135 L. Ed .2d 337 (1996) (quoting Upjohn Co. v. United States, 449 U.S.
383, 393, 101 S. Ct. 677, 66 L. Ed. 2d 584 (1981)). TEC’s disclosure has the same
discouraging effect, as it signals to its provider employees the possibility that it may
use their disclosures against their interests, should doing so be perceived to serve
TEC’s interests. When it disclosed Dr. McSorley’s peer review file to aid its private
interests in an employment discrimination lawsuit, TEC put aside the public’s
interest in encouraging providers—such as Dr. McSorley—to candidly report. The
court is not obligated to protect a privilege more assiduously than its holder does.
Affirmed.
WE CONCUR: